Cencora, Inc. (COR) to Issue Quarterly Dividend of $0.60 on June 1st

Cencora, Inc. (NYSE:COR) announced a quarterly dividend on Tuesday, May 5th. Stockholders of record on Friday, May 15th will be paid a dividend of 0.60 per share on Monday, June 1st. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, May 15th.

Cencora has increased its dividend by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 15 years. Cencora has a dividend payout ratio of 13.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Cencora to earn $19.69 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 12.2%.

Cencora Trading Up 0.6%

Shares of COR stock opened at $261.28 on Wednesday. Cencora has a 1 year low of $244.82 and a 1 year high of $377.54. The firm has a fifty day moving average price of $321.43 and a 200-day moving average price of $340.82. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market cap of $50.83 billion, a price-to-earnings ratio of 20.04, a PEG ratio of 1.20 and a beta of 0.64.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts predict that Cencora will post 17.76 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on COR. Citigroup dropped their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Morgan Stanley set a $342.00 target price on shares of Cencora in a report on Friday. Barclays upped their target price on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Evercore set a $360.00 target price on shares of Cencora in a report on Wednesday, April 8th. Finally, William Blair began coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Cencora currently has an average rating of “Moderate Buy” and an average target price of $380.25.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.